NP
Ninepoint Partners’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,154
| Closed | -$714K | – | 96 |
|
|
2024
Q3 | $714K | Sell |
1,154
-45
| -4% | -$27.8K | 0.08% | 73 |
|
|
2024
Q2 | $663K | Sell |
1,199
-128
| -10% | -$70.8K | 0.06% | 73 |
|
|
2024
Q1 | $771K | Hold |
1,327
| – | – | 0.08% | 59 |
|
|
2023
Q4 | $704K | Buy |
1,327
+117
| +10% | +$62.1K | 0.08% | 52 |
|
|
2023
Q3 | $612K | Hold |
1,210
| – | – | 0.06% | 55 |
|
|
2023
Q2 | $631K | Buy |
1,210
+143
| +13% | +$74.6K | 0.07% | 56 |
|
|
2023
Q1 | $615K | Buy |
1,067
+278
| +35% | +$160K | 0.07% | 48 |
|
|
2022
Q4 | $434K | Buy |
+789
| New | +$434K | 0.06% | 52 |
|
|
2022
Q1 | – | Sell |
-802
| Closed | -$535K | – | 101 |
|
|
2021
Q4 | $535K | Buy |
+802
| New | +$535K | 0.16% | 39 |
|
|
2021
Q2 | – | Sell |
-1,020
| Closed | -$466K | – | 94 |
|
|
2021
Q1 | $466K | Buy |
1,020
+229
| +29% | +$105K | 0.19% | 40 |
|
|
2020
Q4 | $368K | Sell |
791
-282
| -26% | -$131K | 0.14% | 53 |
|
|
2020
Q3 | $474K | Hold |
1,073
| – | – | 0.21% | 16 |
|
|
2020
Q2 | $389K | Sell |
1,073
-230
| -18% | -$83.4K | 0.16% | 30 |
|
|
2020
Q1 | $370K | Sell |
1,303
-306
| -19% | -$86.9K | 0.37% | 24 |
|
|
2019
Q4 | $523K | Hold |
1,609
| – | – | 0.17% | 33 |
|
|
2019
Q3 | $469K | Sell |
1,609
-556
| -26% | -$162K | 0.18% | 46 |
|
|
2019
Q2 | $636K | Sell |
2,165
-1,640
| -43% | -$482K | 0.12% | 39 |
|
|
2019
Q1 | $1.04M | Hold |
3,805
| – | – | 0.19% | 36 |
|
|
2018
Q4 | $852K | Sell |
3,805
-295
| -7% | -$66.1K | 0.23% | 29 |
|
|
2018
Q3 | $1M | Hold |
4,100
| – | – | 0.17% | 38 |
|
|
2018
Q2 | $849K | Buy |
4,100
+1,400
| +52% | +$290K | 0.09% | 40 |
|
|
2018
Q1 | $557K | Buy |
2,700
+1,200
| +80% | +$248K | 0.04% | 57 |
|
|
2017
Q4 | $285K | Buy |
+1,500
| New | +$285K | 0.02% | 101 |
|